Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis

医学 妥珠单抗 银屑病性关节炎 指炎 银屑病 末端炎 依那西普 临床试验 皮肤病科 内科学 类风湿性关节炎
作者
Maria Esposito,Francesco Carubbi,Alessandro Giunta,Alessia Alunno,Roberto Giacomelli,Maria Concetta Fargnoli
出处
期刊:Expert Review of Clinical Immunology [Informa]
卷期号:16 (2): 119-128 被引量:12
标识
DOI:10.1080/1744666x.2020.1713754
摘要

Introduction: Certolizumab pegol (CZP) is an Fc-free PEGylated TNF-α inhibitor approved for the treatment of psoriatic arthritis (PsA) and plaque psoriasis in many countries. It demonstrated favorable results in PsA in terms of improvement in peripheral arthritis, dactylitis, and enthesitis in a phase III trial (RAPID-PSA) and in real-life experiences. Recently, three phase III randomized clinical trials (CIMPASI-1, CIMPASI-2, CIMPACT) showed significant and sustained improvements in signs and symptoms of moderate-to-severe plaque psoriasis as well as in quality of life parameters as compared to placebo and etanercept.Areas covered: We reviewed the structure and the mechanism of action of CZP, and critically analyzed data from clinical trials and real-life, concerning its efficacy and safety in all aspects of the psoriatic disease. We designed a comprehensive literature search on this topic, by a review of published articles in indexed international journals up until 31 July 2019.Expert opinion: CZP demonstrated positive results in several domains of psoriatic disease, also in patients previously exposed to other TNF-α inhibitors and in patients receiving re-treatment after treatment interruption. The peculiar chemical structure, along with its well-established efficacy and safety, support CZP as the drug of choice in specific subgroups of patients with psoriatic disease, in particular patients with comorbidities and pregnant or breastfeeding female patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
带头大哥应助百里守时采纳,获得200
1秒前
3秒前
3秒前
4秒前
Wait完成签到,获得积分10
4秒前
星辰大海应助nidhhog采纳,获得10
5秒前
5秒前
tuanheqi应助尤萨采纳,获得80
5秒前
从容的水壶完成签到,获得积分10
6秒前
6秒前
7秒前
桐桐应助欣喜的成仁采纳,获得10
7秒前
8秒前
9秒前
9秒前
9秒前
10秒前
溧子呀发布了新的文献求助10
10秒前
sunoopp发布了新的文献求助10
11秒前
FFFFF发布了新的文献求助10
11秒前
11秒前
小二郎应助doudou采纳,获得10
13秒前
念念蜜桃乌龙完成签到,获得积分10
13秒前
大模型应助Maize Man采纳,获得10
14秒前
所所应助tRNA采纳,获得10
14秒前
14秒前
15秒前
16秒前
MADKAI发布了新的文献求助30
16秒前
16秒前
二分发布了新的文献求助10
17秒前
17秒前
SciGPT应助真烦人采纳,获得10
17秒前
Lucas应助可爱的彩虹采纳,获得10
18秒前
18秒前
充电宝应助mengmeng0202采纳,获得10
20秒前
21秒前
李健的粉丝团团长应助YANA采纳,获得10
21秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Microlepidoptera Palaearctica, Volumes 1 and 3 - 13 (12-Volume Set) [German] 1122
PraxisRatgeber Mantiden., faszinierende Lauerjäger. – Buch gebraucht kaufen 700
Mantiden - Faszinierende Lauerjäger – Buch gebraucht kaufen 700
Ожившие листья и блуждающие цветы. Практическое руководство по содержанию богомолов [Alive leaves and wandering flowers. A practical guide for keeping praying mantises] 500
Development of a new synthetic process for the synthesis of (S)-methadone and (S)- and (R)-isomethadone as NMDA receptor antagonists for the treatment of depression 500
A Dissection Guide & Atlas to the Rabbit 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3094678
求助须知:如何正确求助?哪些是违规求助? 2746470
关于积分的说明 7590539
捐赠科研通 2397890
什么是DOI,文献DOI怎么找? 1272222
科研通“疑难数据库(出版商)”最低求助积分说明 615340
版权声明 598860